Sage Therapeutics, Inc. Made Big Gain
Mon, Jan 13, 2025 at 07:19 PM
Sage Therapeutics, Inc. (SAGE:NASDAQ) jumped higher at $7.5, representing a gain of 35.1%. On Mon, Jan 13, 2025, SAGE:NASDAQ touched a New 2-Week High of $7.5. The stock appeared on our News Catalysts scanner on Mon, Jan 13, 2025 at 06:21 PM in the 'ACQUISITION' category. From Mon, Dec 30, 2024, the stock recorded 50.00% Up Days and 44.44% Green Days
About Sage Therapeutics, Inc. (SAGE:NASDAQ)
Sage Therapeutics Inc., is a biopharmaceutical company conducting development programs and clinical trials to discover medicines for central nervous system disorders. It has development programs for refractory status epilepticus, and Parkinson's disease.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 290.53%
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 135.26%
- Kairos Pharma Ltd. (KAPA:NYSEMKT), 119.59%
- Azitra Inc (AZTR:NYSEMKT), 59.72%
- Agape ATP Corporation (ATPC:NASDAQ), 56.35%
- Avinger, Inc. (AVGR:NASDAQ), 42.62%
- Neuronetics, Inc. (STIM:NASDAQ), 36.84%
- Sage Therapeutics, Inc. (SAGE:NASDAQ), 35.14%
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 34.07%